US Physical Therapy USPH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 19%+0.9pp | 19.2%+0.7pp | 18.7%-0.2pp | 18.4%-0.8pp | 18.1%-1.4pp | |
| Operating margin | 10%+0.3pp | 11.1%+1.7pp | 11.8%+5.1pp | 10.6%+3.2pp | 9.7%+1.4pp | |
| Net margin | 4.4%-0.4pp | 5.1%+0.4pp | 5.9%+2.4pp | 5.2%+1.2pp | 4.8%0.0pp | |
| EBITDA margin | 12.8%+0.2pp | 14%+1.8pp | 14.9%+5.5pp | 13.6%+3.5pp | 12.6%+1.7pp | |
| Free cash flow margin | 8.4%+0.4pp | 7.8%-2.0pp | 7.5%-3.9pp | 8.3%-2.4pp | 8%-2.8pp | |
| Returns | ||||||
| Return on equity | 7.2%+0.4pp | 8.2%+1.7pp | 9.1%+4.4pp | 7.7%+2.5pp | 6.8%-0.4pp | |
| Return on assets | 2.9%-0.2pp | 3.3%+0.4pp | 4%+1.8pp | 3.5%+0.9pp | 3%0.0pp | |
| Return on invested capital | 11.3%+0.5pp | 12.4%+2.0pp | 13.4%+5.4pp | 11.7%+3.0pp | 10.7%+0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×0.0× | 1×-0.2× | 1.2×-0.6× | 1.2×-0.7× | 1.2×-1.0× | |
| Quick ratio | 1.2×0.0× | 1×-0.2× | 1.2×-0.6× | 1.2×-0.7× | 1.2×-1.0× | |
| Cash ratio | 0.2×-0.1× | 0.3×-0.1× | 0.3×-0.7× | 0.3×-0.8× | 0.3×-1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.1× | 0.3×0.0× | 0.3×+0.1× | 0.3×0.0× | 0.3×+0.1× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | 1.4×+0.1× | 1.2×-0.2× | 1.1×+1.0× | 1.2×+1.0× | 1.3×+1.4× | |
| Per Share | ||||||
| Book value per share | $30.92-5.9% | $31.40-3.3% | $33.12+3.4% | $32.95+2.5% | $32.86+2.9% | |
| Valuation | ||||||
| Market capitalization | $1.01B-10.7% | $1.19B-11.3% | $1.29B+1.3% | $1.2B-13.5% | $1.1B-35.1% | |
| Enterprise value | $1.15B-7.4% | $1.31B-9.4% | $1.42B+10.7% | $1.32B-5.7% | $1.21B-28.1% | |
| Price / earnings | 29×-4.9× | 30×-12.6× | 28.9×-26.9× | 31.5×-23.0× | 33×-25.7× | |
| Price / sales | 1.3×-0.3× | 1.5×-0.5× | 1.7×-0.3× | 1.6×-0.6× | 1.6×-1.2× | |
| Price / book | 2.1×-0.1× | 2.5×-0.2× | 2.6×-0.1× | 2.4×-0.5× | 2.2×-1.3× | |
| EV / EBITDA | 11.3×-2.8× | 12.1×-5.7× | 12.5×-8.6× | 13.3×-8.9× | 13.7×-11.4× | |
| EV / sales | 1.4×-0.3× | 1.7×-0.5× | 1.9×-0.1× | 1.8×-0.4× | 1.7×-1.0× | |
| Free cash flow yield | 6.6%+1.7pp | 5.1%+0.2pp | 4.4%-1.4pp | 5.1%+0.2pp | 5.1%+1.2pp | |
| Earnings yield | 3.4%+0.5pp | 3.3%+1.0pp | 3.5%+1.7pp | 3.2%+1.3pp | 3%+1.3pp | |
| PEG ratio | 6.7×+4.5× | 1.2×-2.6× | 0.3×— | 0.6×— | 2.2×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are US Physical Therapy's profit margins?
- US Physical Therapy (USPH) runs a 19.0% gross margin and a 10.0% operating margin, with a 4.4% net margin.
- Where do US Physical Therapy's ratios come from?
- Every ratio is computed from US Physical Therapy's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
